Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 20, 2026 20:28 ET | Source: Robbins Geller Rudman & Dowd LLP

INVESTOR ALERT: Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead the Corcept Class Action Lawsuit – RGRD Law

The lawsuit alleges that defendants failed to disclose that the FDA raised concerns about the adequacy of evidence supporting relacorilant’s NDA.
February 19, 2026 08:19 ET | Source: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
February 17, 2026 08:16 ET | Source: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
February 12, 2026 10:12 ET | Source: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
February 10, 2026 10:47 ET | Source: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
February 09, 2026 10:58 ET | Source: Schall Law

CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm

CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
February 05, 2026 10:47 ET | Source: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
February 04, 2026 17:10 ET | Source: Bragar Eagel & Squire

CORCEPT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Encourages Corcept Therapeutics Investors to Contact the Firm Regarding Ongoing Investigation

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Corcept (CORT) To Contact Him Directly To Discuss Their Options If you purchased or...
February 02, 2026 03:33 ET | Source: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
January 30, 2026 15:28 ET | Source: Hagens Berman Sobol Shapiro LLP

Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application – Hagens Berman

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.